Analog Method for Radiographic Assessment of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva

Pignolo, 2011, Fibrodysplasia ossificans progressiva: clinical and genetic aspects, Orphanet J Rare Dis, 6, 80, 10.1186/1750-1172-6-80 Kaplan, 2008, Fibrodysplasia ossificans progressiva, Best Pract Res Clin Rheumatol, 22, 191, 10.1016/j.berh.2007.11.007 Shore, 2006, A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva, Nat Genet, 38, 525, 10.1038/ng1783 Kan, 2011, Substance P signaling mediates BMP-dependent heterotopic ossification, J Cell Biochem, 112, 2759, 10.1002/jcb.23259 Kaplan, 2007, A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton, Expert Opin Biol Ther, 7, 705, 10.1517/14712598.7.5.705 Shimono, 2011, Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-gamma agonists, Nat Med, 17, 454, 10.1038/nm.2334 Yu, 2008, BMP type I receptor inhibition reduces heterotopic [corrected] ossification, Nat Med, 14, 1363, 10.1038/nm.1888 Hatsell, 2015, ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A, Sci Transl Med, 7, 303ra137, 10.1126/scitranslmed.aac4358 Brooker, 1973, Ectopic ossification following total hip replacement. Incidence and a method of classification, J Bone Joint Surg Am, 55, 1629, 10.2106/00004623-197355080-00006 Kawaguchi, 2011, Evaluation of ossification of the posterior longitudinal ligament by three-dimensional computed tomography and magnetic resonance imaging, Spine J, 11, 927, 10.1016/j.spinee.2011.08.013 Kocic, 2010, Clinical significance of the heterotopic ossification after total hip arthroplasty, Orthopedics, 33, 16, 10.3928/01477447-20091124-13 Mavrogenis, 2012, A classification method for neurogenic heterotopic ossification of the hip, J Orthop Traumatol, 13, 69, 10.1007/s10195-012-0193-z Schuh, 2005, [The modified Brooker classification for evaluation of heterotopic ossifications in total hip replacement], Zentralbl Chir, 130, 293, 10.1055/s-2005-836783 Fukuda, 2006, Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2, Genesis, 44, 159, 10.1002/dvg.20201 Brownley, 2015, Characterization of heterotopic ossification using radiographic imaging: evidence for a paradigm shift, PLoS ONE, 10, e0141432, 10.1371/journal.pone.0141432 Kaplan, 2011, The medical management of fibrodysplasia ossificans progressiva: current treatment considerations, Clin Proc Intl Clin Consort FOP, 4, 1 Kaplan, 1994, Radiographic and scintigraphic features of modeling and remodeling in the heterotopic skeleton of patients who have fibrodysplasia ossificans progressiva, Clin Orthop Relat Res, 304, 238 Kaplan, 2009, Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1, Hum Mutat, 30, 379, 10.1002/humu.20868 Mahboubi, 2001, Fibrodysplasia ossificans progressiva, Pediatr Radiol, 31, 307, 10.1007/s002470100447